Dr. Casey Kowalik discusses the benefits of the KU Urology Residency Program

In this interview, William P. Parker, MD, highlights the development of PSMA-PET imaging in prostate cancer, FDA-approved PSMA-PET agents, and the next steps with this disruptive technique.

On this podcast, Bristol Whiles, MD, discusses her urology residency experience at the Kansas University School of Medicine Department of Urology.

On this podcast, Lieutenant Colonel Matthew Banti, MD, FACS, a recent graduate of the Urologic Oncology fellowship at the University of Kansas Health System, is interviewed about his career journey as a urologist in the United States Army.

A recent study published in Urology described how American Urological Association–accredited urological residency training programs are organized in terms of clinical exposure and teaching of their residents.

To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.